Evicenter
Trodelvy (sacituzumab govitecan-hziy) in Metastatic triple-negative breast cancer
Manufacturer
Gilead Sciences, Inc.
Prescribing information
Trodelvy (opens in a new tab)
Questions
47
Last updated

All questions

Dosing and administration: Trodelvy (sacituzumab govitecan-hziy) in metastatic triple-negative breast cancer

9 questions · 6 sources

Dosing

What is the TRODELVY dose and treatment schedule?

What is the maximum dose of TRODELVY?

How should the TRODELVY dose be modified for side effects?

Note: The dosage reduction levels appear as an image on the safety page and are quoted from the linked Prescribing Information.

Treatment combinations

Who is eligible for TRODELVY plus pembrolizumab in metastatic TNBC?

With TRODELVY, how long is pembrolizumab continued?

Preparation

How should TRODELVY vials be stored?

How is a TRODELVY vial reconstituted?

Note: Covers vial reconstitution; dilution and administration steps are in the linked reconstitution guide.

Administration

What premedications are recommended before each TRODELVY infusion?

How long does a TRODELVY infusion take?